These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Repeatability of Quantitative Jansen BHE; Cysouw MCF; Vis AN; van Moorselaar RJA; Voortman J; Bodar YJL; Schober PR; Hendrikse NH; Hoekstra OS; Boellaard R; Oprea-Lager DE J Nucl Med; 2020 Sep; 61(9):1320-1325. PubMed ID: 31924729 [TBL] [Abstract][Full Text] [Related]
4. Combined Early and Late [ Hohberg M; Kobe C; Täger P; Hammes J; Schmidt M; Dietlein F; Wild M; Heidenreich A; Drzezga A; Dietlein M Mol Imaging Biol; 2019 Jun; 21(3):558-566. PubMed ID: 30105521 [TBL] [Abstract][Full Text] [Related]
5. High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with Werner RA; Habacha B; Lütje S; Bundschuh L; Higuchi T; Hartrampf P; Serfling SE; Derlin T; Lapa C; Buck AK; Essler M; Pienta KJ; Eisenberger MA; Markowski MC; Shinehouse L; AbdAllah R; Salavati A; Lodge MA; Pomper MG; Gorin MA; Bundschuh RA; Rowe SP Mol Imaging; 2022; 2022():7056983. PubMed ID: 35283693 [TBL] [Abstract][Full Text] [Related]
6. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients. Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731 [TBL] [Abstract][Full Text] [Related]
7. Schmidkonz C; Cordes M; Schmidt D; Bäuerle T; Goetz TI; Beck M; Prante O; Cavallaro A; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1862-1872. PubMed ID: 29725716 [TBL] [Abstract][Full Text] [Related]
8. Prospective inter- and intra-tracer repeatability analysis of radiomics features in [ Kendrick J; Francis RJ; Hassan GM; Rowshanfarzad P; Ong JSL; Jeraj R; Barry N; Hagan T; Ebert MA Br J Radiol; 2023 Dec; 96(1152):20221178. PubMed ID: 37751168 [TBL] [Abstract][Full Text] [Related]
9. Initial Experience with Volumetric Schmuck S; von Klot CA; Henkenberens C; Sohns JM; Christiansen H; Wester HJ; Ross TL; Bengel FM; Derlin T J Nucl Med; 2017 Dec; 58(12):1962-1968. PubMed ID: 28522740 [TBL] [Abstract][Full Text] [Related]
10. Semi-automatic evaluation of baseline whole-body tumor burden as an imaging biomarker of Zou Q; Jiao J; Zou MH; Li MZ; Yang T; Xu L; Zhang Y Abdom Radiol (NY); 2020 Dec; 45(12):4202-4213. PubMed ID: 32948911 [TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
12. A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [ Lv J; Yu H; Yin H; Shi Y; Shi H Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):919-927. PubMed ID: 37940684 [TBL] [Abstract][Full Text] [Related]
13. qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using Gafita A; Bieth M; Krönke M; Tetteh G; Navarro F; Wang H; Günther E; Menze B; Weber WA; Eiber M J Nucl Med; 2019 Sep; 60(9):1277-1283. PubMed ID: 30850484 [TBL] [Abstract][Full Text] [Related]
14. Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer. Dietlein M; Kobe C; Kuhnert G; Stockter S; Fischer T; Schomäcker K; Schmidt M; Dietlein F; Zlatopolskiy BD; Krapf P; Richarz R; Neubauer S; Drzezga A; Neumaier B Mol Imaging Biol; 2015 Aug; 17(4):575-84. PubMed ID: 26013479 [TBL] [Abstract][Full Text] [Related]
15. A Multicenter Prospective Clinical Trial of McCarthy M; Francis R; Tang C; Watts J; Campbell A Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):801-808. PubMed ID: 30890448 [TBL] [Abstract][Full Text] [Related]
16. Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer. Oprea-Lager DE; Kramer G; van de Ven PM; van den Eertwegh AJ; van Moorselaar RJ; Schober P; Hoekstra OS; Lammertsma AA; Boellaard R J Nucl Med; 2016 May; 57(5):721-7. PubMed ID: 26697964 [TBL] [Abstract][Full Text] [Related]
17. von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Zamboglou C; Drendel V; Jilg CA; Rischke HC; Beck TI; Schultze-Seemann W; Krauss T; Mix M; Schiller F; Wetterauer U; Werner M; Langer M; Bock M; Meyer PT; Grosu AL Theranostics; 2017; 7(1):228-237. PubMed ID: 28042330 [TBL] [Abstract][Full Text] [Related]
19. Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in Patients With Early Recurrent Prostate Cancer. Rauscher I; Maurer T; Souvatzoglou M; Beer AJ; Vag T; Wirtz M; Weirich G; Wester HJ; Gschwend JE; Schwaiger M; Schottelius M; Eiber M Clin Nucl Med; 2016 Sep; 41(9):e397-402. PubMed ID: 27276206 [TBL] [Abstract][Full Text] [Related]
20. Preliminary results on response assessment using Seitz AK; Rauscher I; Haller B; Krönke M; Luther S; Heck MM; Horn T; Gschwend JE; Schwaiger M; Eiber M; Maurer T Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):602-612. PubMed ID: 29185010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]